About Nuovo Ospedale Civile S. Agostino-Estense
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Janssen Sciences Ireland UC
2
Alector Inc.
1
Consorzio Futuro in Ricerca
1
CymaBay Therapeutics, Inc.
1
Daiichi Sankyo, Inc.
1
Janssen Pharmaceutica N.V., Belgium
1
Nuovo Ospedale Civile S.Agostino Estense
1
Clinical Trials at Nuovo Ospedale Civile S. Agostino-Estense
During the past decade, Nuovo Ospedale Civile S. Agostino-Estense conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Early Pancreatic Duct Stent Removal in Preventing Post-endoscopic Pancreatitis
2009-12-01
2011-06-01
Completed
40
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
2012-08-22
2019-12-13
Completed
10,471
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)
2016-12-13
2018-06-22
Completed
120
Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation
2015-08-01
2022-04-13
Completed
13,980
ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
2018-10-01
2020-02-16
Completed
265
Functional Assessment in Elderly MI Patients With Multivessel Disease
2019-07-15
2026-10-03
Active, not recruiting
1,445
A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection
2019-08-01
2022-04-26
Completed
471
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Nuovo Ospedale Civile S. Agostino-Estense" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Janssen Sciences Ireland UC" with 2 trials
sponsored, "Alector Inc." with 1 trials sponsored, "Consorzio Futuro in Ricerca" with 1 trials sponsored and "CymaBay Therapeutics, Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nuovo Ospedale Civile S. Agostino-Estense"
#1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Nuovo Ospedale Civile S. Agostino-Estense
According to Clinical.Site data, the most researched conditions in "Nuovo Ospedale Civile S. Agostino-Estense" are
"Hepatitis B, Chronic" (3 trials), "Atrial Fibrillation" (2 trials), "Stroke" (2 trials), "Acute Pancreatitis" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Nuovo Ospedale Civile S. Agostino-Estense" in a lesser frequency.
Clinical Trials Intervention Types at Nuovo Ospedale Civile S. Agostino-Estense
Most popular intervention types in "Nuovo Ospedale Civile S. Agostino-Estense" are "Drug" (7 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "JNJ-56136379" (2 trials), "JNJ-73763989" (2 trials), "Placebo" (2 trials), "Placebo for JNJ-56136379" (2 trials) and "Placebo for JNJ-73763989" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Nuovo Ospedale Civile S. Agostino-Estense
The vast majority of trials in "Nuovo Ospedale Civile S. Agostino-Estense" are
11 trials for "All" genders.
Clinical Trials Status at Nuovo Ospedale Civile S. Agostino-Estense
Currently, there are NaN active trials in "Nuovo Ospedale Civile S. Agostino-Estense".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Nuovo Ospedale Civile S. Agostino-Estense,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nuovo Ospedale Civile S. Agostino-Estense, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".